Search

Neuromod launches Ótologie specialist tinnitus care service

Medical device company, Neuromod Devices Ltd, has launched a specialist tinnitus care service, Ótologie.

Rapid, non-invasive and differential diagnosis of laryngopharyngeal reflux

Laryngopharyngeal reflux (LPR) is a significant condition that frequently goes undiagnosed at a primary care level, resulting in patients being unnecessarily referred to secondary care with symptoms such as a sore throat, persistent cough, vocal problems and issues with swallowing.

free Stage 3D desktop scanner

The free Stage 3D desktop scanner was developed in 2019 in Germany for quality conscious audiologists.

New global alliance brings hearing care to people in 14 developing countries

A global project from MED-EL will provide access to new ear and hearing care services for almost 100,000 people living with undiagnosed and untreated hearing loss in developing and emerging countries around the world.

William Demant Foundation Donates DKK 8 Million ($1.2 Million USD) for Humanitarian Aid Inside and Outside Ukraine

The William Demant Foundation has announced plans to donate DKK 8 million ($1.2 million USD) to support humanitarian aid in and outside Ukraine to meet the growing needs of children and families, including those on the move.

Streamlining ENT pathways

Laryngopharyngeal reflux (LPR) may present with severe extra-gastrointestinal symptoms – including a persistent cough, vocal problems, asthma or difficulty swallowing – that can be incorrectly attributed to ENT problems because patients and GPs alike assume they stem from colds, allergies or over-using the voice.

Neuromod establishes global leadership team following launch of Lenire in Spain

Neuromod Devices has announced the formation of a global commercial leadership team to further commercialise its Lenire tinnitus treatment device through key partnerships.

Lenire®, the tinnitus treatment device, now available in Norway

Neuromod Devices Ltd., has reached an agreement with HØR AS, Norway’s largest private provider of hearing and tinnitus care, to make its Lenire tinnitus treatment device available in Norway.

Soluvos Medical is looking forward to the congress season 2022

The Soluvos team is preparing for the summer break. In the meantime, they can be found at the following events

Neuromod publishes results of second large-scale clinical trial for tinnitus, shows greater improvement of symptoms

Neuromod Devices, the medical device company specialising in tinnitus, has published the results of its TENT-A2 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A2) clinical trial in the scientific journal, Nature – Scientific Reports in a paper titled ‘Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial’.

The central ENT decontamination model: a help or a hindrance?

According to NHS England, over 400,000 patients were waiting for ENT treatment in the UK in January 2022. This figure forms part of the overall 33.5% increase in the number of patients waiting for Referral to Treatment (RTT) compared to February 2020[1].

Hearing Care Centre Ipswich relocates to new state-of-the-art clinic

Audiology & aural care experts at the Hearing Care Centre expand operations in Ipswich with the relocation of their flagship clinic.